You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0352 Tofacitinib treatment is associated with attainment of the minimally important reduction in axial mri inflammation in patients with ankylosing spondylitis

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Spondyloarthritis - treatment
THU0352 Tofacitinib treatment is associated with attainment of the minimally important reduction in axial mri inflammation in patients with ankylosing spondylitis
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20171503
Jul 20173000
Aug 20172404
Sep 20175004
Oct 20172002
Nov 20171601
Dec 20174802
Jan 20183003
Feb 2018800
Mar 20181601
Apr 2018801
May 20181800
Jun 20181000
Jul 20181202
Aug 2018800
Sep 2018201
Oct 2018200
Nov 2018201
Dec 2018200
Jan 2019201
Feb 2019400
Mar 2019003
Apr 2019402
May 2019505
Jun 2019602
Jul 20191004
Aug 2019603
Sep 2019001
Oct 20191005
Nov 2019003
Dec 2019601
Feb 2020001
Mar 2020802
Apr 2020804
May 20201203
Jun 2020801
Jul 2020602
Aug 2020202
Sep 20201401
Oct 2020400
Nov 20201003
Dec 2020603
Jan 2021602
Feb 2021604
Mar 2021001
Apr 2021403
May 2021001
Jun 2021004
Jul 2021003
Sep 2021003
Oct 20210015
Nov 202112012
Dec 2021201
Jan 2022401
Feb 2022200
Mar 2022303
Apr 20222802
May 202210010
Jun 2022603
Jul 2022801
Aug 20221103
Sep 2022207
Oct 20221404
Dec 2022601
Jan 2023603
Feb 2023400
Mar 20231001
Apr 2023605
May 2023403
Jun 2023501
Jul 2023204
Aug 2023001
Sep 2023201
Oct 2023202
Nov 2023001
Dec 2023800
Jan 2024401
Feb 2024201
Mar 20242016
Total6330201